Trademark Overview
On Tuesday, December 3, 2024, a trademark application was filed for TOVALT with the United States Patent and Trademark Office. The USPTO has given the TOVALT trademark a serial number of 98882592. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 3, 2024. This trademark is owned by Newcastle Bioscience, LLC. The TOVALT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's dise...
